Literature DB >> 16580947

Positron emission tomography and magnetic resonance imaging in heart failure.

Frank M Bengel1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16580947     DOI： 10.1007/bf02971235

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  20 in total

1.  Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography.

Authors:  Christoph Klein; Stephan G Nekolla; Frank M Bengel; Mitsuru Momose; Andrea Sammer; Felix Haas; Bernhard Schnackenburg; Wolfram Delius; Harald Mudra; Dieter Wolfram; Markus Schwaiger
Journal:  Circulation       Date:  2002-01-15       Impact factor: 29.690

2.  Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction.

Authors:  Khaldoun G Tarakji; Richard Brunken; Patrick M McCarthy; M Obadah Al-Chekakie; Ahmed Abdel-Latif; Claire E Pothier; Eugene H Blackstone; Michael S Lauer
Journal:  Circulation       Date:  2006-01-03       Impact factor: 29.690

3.  Non-invasive estimation of myocardial efficiency using positron emission tomography and carbon-11 acetate--comparison between the normal and failing human heart.

Authors:  F M Bengel; B Permanetter; M Ungerer; S Nekolla; M Schwaiger
Journal:  Eur J Nucl Med       Date:  2000-03

4.  Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease.

Authors:  F Haas; C J Haehnel; W Picker; S Nekolla; S Martinoff; H Meisner; M Schwaiger
Journal:  J Am Coll Cardiol       Date:  1997-12       Impact factor: 24.094

5.  Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study.

Authors:  Anja Wagner; Heiko Mahrholdt; Thomas A Holly; Michael D Elliott; Matthias Regenfus; Michele Parker; Francis J Klocke; Robert O Bonow; Raymond J Kim; Robert M Judd
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

6.  Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery.

Authors:  Ernst Wellnhofer; Adriana Olariu; Christoph Klein; Michael Gräfe; Andreas Wahl; Eckart Fleck; Eike Nagel
Journal:  Circulation       Date:  2004-04-26       Impact factor: 29.690

7.  Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data.

Authors:  J J Bax; W Wijns; J H Cornel; F C Visser; E Boersma; P M Fioretti
Journal:  J Am Coll Cardiol       Date:  1997-11-15       Impact factor: 24.094

8.  Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging.

Authors:  R S Beanlands; P J Hendry; R G Masters; R A deKemp; K Woodend; T D Ruddy
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

9.  Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.

Authors:  F M Baer; E Voth; C A Schneider; P Theissen; H Schicha; U Sechtem
Journal:  Circulation       Date:  1995-02-15       Impact factor: 29.690

10.  Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography.

Authors:  D Eitzman; Z al-Aouar; H L Kanter; J vom Dahl; M Kirsh; G M Deeb; M Schwaiger
Journal:  J Am Coll Cardiol       Date:  1992-09       Impact factor: 24.094
View more
  2 in total

1.  Myocardial viability by contrast-enhanced cardiovascular magnetic resonance in patients with coronary artery disease: comparison with gated single-photon emission tomography and FDG position emission tomography.

Authors:  Yen-Wen Wu; Eiji Tadamura; Shotaro Kanao; Masaki Yamamuro; Akira Marui; Masashi Komeda; Masanao Toma; Takeshi Kimura; Kaori Togashi
Journal:  Int J Cardiovasc Imaging       Date:  2007-03-16       Impact factor: 2.357

Review 2.  Nuclear cardiology and heart failure.

Authors:  Raffaele Giubbini; Elisa Milan; Francesco Bertagna; Fernando Mut; Marco Metra; Carlo Rodella; Maurizio Dondi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.